Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

395
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
395
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

338
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
338
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

468
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
468
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of the "2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade" on Quantitative Neuromuscular Monitoring Two Years Later.

Anesthesia and analgesia·2026
Same author

Quantitative Photo-Reforming of Biomass to CO Spurred by In Situ Protonation of Carbon Dioxide Radical Anions.

Angewandte Chemie (International ed. in English)·2026
Same author

Error Traps in Pediatric Neuromuscular Block.

Paediatric anaesthesia·2026
Same author

Hand Size Measurements in Children Aged 1-15 Years to Help the Development of Pediatric Electromyography Sensors for Neuromuscular Monitoring.

Journal of clinical medicine·2025
Same author

The Neuromuscular Junction: A Shared Vulnerability in Aging and Disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

A benign and scalable reverse water-gas shift reaction in EMIM acetate with Ru-PNP catalysts.

Chemical communications (Cambridge, England)·2025

Related Experiment Video

Updated: Jun 9, 2025

Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations
09:50

Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations

Published on: January 25, 2018

6.7K

ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in Rats.

Marianne Skals1, Martin Broch-Lips1, Martin Brandhøj Skov1

  • 1NMD Pharma, Aarhus, Denmark.

Nature Communications
|October 29, 2024
PubMed
Summary

Inhibition of the ClC-1 channel accelerates skeletal muscle function recovery after surgery. This finding offers a potential new method for reversing neuromuscular blocking agents, improving patient safety.

More Related Videos

Procedures for Rat in situ Skeletal Muscle Contractile Properties
09:49

Procedures for Rat in situ Skeletal Muscle Contractile Properties

Published on: October 15, 2011

28.6K
A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation
08:24

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

Published on: May 9, 2012

21.0K

Related Experiment Videos

Last Updated: Jun 9, 2025

Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations
09:50

Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations

Published on: January 25, 2018

6.7K
Procedures for Rat in situ Skeletal Muscle Contractile Properties
09:49

Procedures for Rat in situ Skeletal Muscle Contractile Properties

Published on: October 15, 2011

28.6K
A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation
08:24

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

Published on: May 9, 2012

21.0K

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Physiology

Background:

  • Neuromuscular blocking agents are essential for surgery but can cause residual block, increasing postoperative pulmonary complication risks.
  • Current reversal agents have limitations, highlighting the need for a universal and safe antagonist.
  • Adequate recovery of muscle function is critical for supporting post-surgical pulmonary function.

Purpose of the Study:

  • To investigate the potential of ClC-1 channel inhibition as a mechanism to accelerate neuromuscular function recovery.
  • To evaluate the efficacy of ClC-1 inhibition in reversing neuromuscular blockade in a preclinical model.

Main Methods:

  • Utilized a rat model to simulate neuromuscular blocking agent-induced muscle block during surgery.
  • Assessed the impact of inhibiting the skeletal muscle-specific chloride ion (ClC-1) channel on muscle contraction recovery.
  • Monitored both single contraction (twitch) and sustained (tetanic) contractions.

Main Results:

  • Inhibition of the ClC-1 channel significantly accelerated the recovery of single muscle contractions (twitch).
  • Crucially, ClC-1 channel inhibition also markedly enhanced the recovery of sustained muscle contractions (tetanic).
  • These results demonstrate a robust effect on both types of muscle activity.

Conclusions:

  • ClC-1 channel inhibition presents a promising mechanism for rapid and effective reversal of neuromuscular blockade.
  • This approach could potentially antagonize all types of neuromuscular blocking agents, addressing a significant clinical need.
  • Further research into ClC-1 inhibition could lead to improved patient outcomes following surgeries involving neuromuscular blockade.